EP3860662A1 - Method for inactivating biologically active components in a liquid - Google Patents
Method for inactivating biologically active components in a liquidInfo
- Publication number
- EP3860662A1 EP3860662A1 EP19778498.6A EP19778498A EP3860662A1 EP 3860662 A1 EP3860662 A1 EP 3860662A1 EP 19778498 A EP19778498 A EP 19778498A EP 3860662 A1 EP3860662 A1 EP 3860662A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- liquid
- vessel
- volume
- low
- partial volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/087—Particle radiation, e.g. electron-beam, alpha or beta radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L11/00—Methods specially adapted for refuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/26—Accessories or devices or components used for biocidal treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/12—Apparatus for isolating biocidal substances from the environment
- A61L2202/122—Chambers for sterilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/14—Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
Definitions
- the invention relates to a method for inactivating biologically active components within a liquid.
- Liquid waste which contains biologically active components such as microorganisms or vegetable residues, falls primarily in the pharmaceutical and
- Biosafety classes Biologically contaminated liquid or solid waste is assigned to different biosafety classes. So far, such waste has mainly been chemically or thermally activated, which means that the microbiological contamination in the form of viruses, bacteria, micro-fungi and possibly prions has been eliminated.
- activating is to be understood below to mean that the health-damaging effect of biologically active constituents of a liquid is eliminated. On the one hand, this can mean that the biologically active constituents of a liquid are sterilized and / or destroyed. On the other hand, it can already be sufficient if the biologically active constituents of the liquid are influenced in such a way that they are no longer capable of replication or that the number of reproducible biologically active constituents of the liquid is reduced by their
- biologically active constituents includes all those constituents which trigger a reaction in living organisms.
- Biologically active constituents of a liquid can thus be, for example, viruses, bacteria, fungi, yeasts, algae, prions, protozoa, plant constituents or hormones. This list is only exemplary and is not to be considered as comprehensive.
- microbiologically contaminated waste ranges from aqueous liquids to chicken eggs from vaccine production to animal bodies such as experimental mice. But the manure from animal husbandry is also often contaminated with bacteria such as Salmonella, which should be inactivated before being applied to fields.
- Germ reduction is suitable on masses that have liquid components.
- EP 0 024 487 A1 shows a solution in which a liquid is first conveyed onto a plateau from which it falls as a liquid curtain and during which time it is irradiated once from one side.
- the disadvantage here is that
- Components of the liquid on the front of the liquid curtain are exposed to a higher radiation dose than components on the back of the liquid curtain. If all of the biologically active components on the back of the liquid curtain are to be deactivated during the one radiation process, the radiation must be so strongly adjusted that this can damage or destroy the biologically active components on the front of the liquid curtain.
- a method for inactivating pathogens in biological media is known from DE 10 2016 21 6 573 A1, in which a roller set in rotation is partially immersed in a liquid on its underside, so that a liquid film is formed on the top of the roller as a result of the rotation of the roller trains which is exposed to ionizing radiation. After loading the liquid film with
- the liquid film is stripped off the roller and
- the invention is therefore based on the technical problem of creating a method for inactivating a liquid containing biologically active constituents, by means of which the disadvantages of the prior art can be overcome.
- the method according to the invention it should also be possible with the method according to the invention to inactivate biologically active constituents of a liquid without destroying or damaging the biologically active constituents of the liquid.
- the process according to the invention is based only on doing radiation passage, mostly using high-energy, accelerated electrons To apply partial volumes of a batch of material with accelerated electrons, but several times and with very small doses of accelerated electrons.
- Components within a liquid by means of low-energy electrons generated by an electron source are electrons with an acceleration voltage of 25 keV to 300 keV.
- a liquid volume of the liquid containing biologically active components is filled into a vessel.
- a vessel can be, for example, a bioreactor or any other vessel that is suitable for holding a liquid.
- a first partial volume of the liquid filled into the vessel is included
- the first partial volume comprising a maximum of 10% of the liquid volume in the vessel.
- the method according to the invention is further characterized in that at least 90% of the energy of the low-energy electrons generated by the electron source is applied within the first partial volume.
- the second partial volume at that point in time is the partial volume in the vessel which is not subjected to accelerated electrons at this point in time or into which a maximum of 10% of the energy of the low-energy electrons is introduced.
- the first partial volume of the liquid charged with low-energy electrons is mixed with the second liquid partial volume in the vessel, which was not charged with low-energy electrons.
- a first partial volume of the liquid filled into the vessel is acted upon by low-energy electrons and then mixed with the second partial volume not acted on by low-energy electrons.
- the application of low-energy electrons to a first partial volume and the mixing of the first partial volume with the second partial volume is repeated several times and until all biologically active components of the liquid volume in the vessel are inactivated.
- the fact that only a relatively small part of the volume in relation to the total volume in a vessel and the small part of the volume is only subjected to low-energy electrons means that gentle inactivation of biologically active components within a liquid can be implemented without the biologically active components in the liquid to damage or destroy. It is therefore particularly advantageous if the first partial volume, which is charged with low-energy electrons, only comprises a maximum of 5% of the liquid volume in the vessel.
- Irradiation period is applied with a maximum of 1% of the total amount of low-energy electrons that is required to inactivate all biologically active components within the first partial volume of the liquid.
- the application of such a low dose of low-energy electrons to a relatively small partial volume to be irradiated makes it necessary to inactivate all biologically active ones
- Components in the entire liquid volume in the vessel require multiple irradiation of the first partial volume and multiple mixing of a currently irradiated first partial volume with a second partial volume that is not currently irradiated, but this has the advantage that all particles of the liquid have the same average Total dose of low-energy electrons are applied.
- a partial region of a wall of the vessel is formed as an electron exit window of the electron source, through which low-energy electrons penetrate into the first partial volume of the liquid within the vessel, means for mixing the liquid in the vessel having the effect that the composition of the first Partial volume of the liquid in the vessel changed.
- the first partial volume of the liquid volume can also be removed from the vessel, charged with low-energy electrons outside the vessel and then mixed with the second liquid volume remaining in the vessel.
- FIG. 1 shows a device suitable for carrying out the method according to the invention in a schematic sectional illustration
- FIG. 1 a device is shown schematically in a section, which for
- a volume 12 of a liquid containing biologically active constituents is initially filled into a vessel 11, in which the biologically active constituents are to be inactivated.
- One wall of the vessel 11 is formed in one area as an electron exit window 13 of an electron source 14.
- Low-energy electrons with an acceleration voltage of 25 keV to 300 keV enter a first partial volume 15 of the liquid volume 12 through the electron exit window 13.
- the depth of penetration of accelerated electrons and the distribution of the energy introduced into a medium also change Medium such as a liquid
- Medium such as a liquid
- the electrical parameters of the electron source 14 according to the invention such that the first partial volume 15 acted upon by the low-energy electrons of the electron source 14 makes up a maximum of 10% and preferably a maximum of 5% of the liquid volume 12 and that at least 90% of the energy of the low-energy electrons is entered into this first partial volume 1 5.
- Irradiation time period with a maximum of 1% of the total amount of low-energy electrons which is required to inactivate all biologically active components within the first partial volume 15 of the liquid.
- a person skilled in the art can also set the electrical parameters of the electron source 14 in such a way that during a radiation period a maximum of 1% of the total amount of low-energy electrons penetrate into the partial volume 15, which is required to inactivate all biologically active constituents within the partial volume 15 will.
- Means 16 ensure that a first partial volume 15 charged with low-energy electrons is mixed with the second partial volume not charged with low-energy electrons, as a result of which the composition of the first partial volume 15 also changes, and thus a new first partial volume 15 is continuously formed.
- the application of the first partial volume 1 5 with low-energy electrons and the mixing of the liquid in the vessel 1 1 continue until one of the A liquid sample taken from vessel 1 shows that the biologically active components in the liquid are sufficiently inactivated.
- electron source 14 is used throughout
- Liquid volume 12 operated continuously and with constant performance.
- the electron source 14 can also be activated only periodically at time intervals, the periods of time when the electron source is activated being the same length or
- the liquid in the vessel 11 is continuously mixed with the agents 16 during the entire inactivation process of all biologically active constituents within the liquid volume 12 in the vessel 11.
- the liquid in the vessel 11 can also be mixed only periodically at time intervals, it being possible for the time intervals to be of the same length or of different lengths.
- FIG. 2 An alternative device for carrying out the method according to the invention is shown schematically in a section in FIG. 2.
- a vessel 21 is first a
- Filled liquid volume 22 of a liquid containing biologically active components, in which the biologically active components are to be inactivated A continuous flow of the liquid located in the vessel 21 is branched off by means of at least one pump device 27, conveyed through a pipeline 28 and then returned to the vessel 21.
- One wall of the pipeline 28 is formed in one area as an electron exit window 23 of an electron source 24.
- Low-energy electrons with an acceleration voltage of 25 keV to 300 keV enter a first partial volume 25 of the liquid volume 22 through the electron exit window 23.
- the pipeline 28 and the electron source 24 are dimensioned such that the low-energy electrons generated by the electron source 24 each have only a first one Apply partial volume 25, which is a maximum of 10% and preferably a maximum of 5% from
- Liquid volume 22 makes up, with at least 90% of the energy of
- the flow velocity of the liquid in the pipeline 28 and the electrical parameters of the electron source 24 are set in such a way that in a first partial volume 25 during one pass (that is, when it is once
- Electron exit window 25 flows past) a maximum of 1% of the total amount
- the charging of the first partial volume 25 with low-energy electrons and the mixing of the liquid in the vessel 21 continue until a liquid sample taken from the vessel 21 shows that the biologically active constituents in the liquid have been sufficiently inactivated.
- the continuous flow is branched off from the liquid in the vessel 21 in a lower region of the vessel 21 and reintroduced in an upper region of the vessel 21, then this process alone ensures constant mixing liquid in the vessel 21.
- the liquid in the vessel 21 can also be mixed continuously or at intervals by means of means 26.
- FIGS. 1 and 2 require a relatively long time in relation to the methods known from the prior art for inactivating biologically active constituents in a liquid, but are advantageous in applications in which all constituents of a liquid with a continuously homogeneous dose of accelerated electrons and / or in which the biologically active components are not to be destroyed.
- the method according to the invention can be used, for example, in bioreactors for producing vaccines or else in wastewater treatment.
- At least one sensor can also be arranged within the regions of the first partial volumes 15 and 25, respectively, with which the intensity of the current of accelerated, low-energy electrons; their distribution in partial volume 15 or 25 and / or the dose of the low-energy electrons applied in partial volume 15 or 25 can be detected and controlled by means of an evaluation device.
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102018124664.1A DE102018124664A1 (en) | 2018-10-05 | 2018-10-05 | Process for inactivating biologically active components within a liquid |
PCT/EP2019/075926 WO2020069942A1 (en) | 2018-10-05 | 2019-09-25 | Method for inactivating biologically active components in a liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3860662A1 true EP3860662A1 (en) | 2021-08-11 |
Family
ID=68069775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19778498.6A Pending EP3860662A1 (en) | 2018-10-05 | 2019-09-25 | Method for inactivating biologically active components in a liquid |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210379218A1 (en) |
EP (1) | EP3860662A1 (en) |
KR (1) | KR20210070353A (en) |
CN (1) | CN112789060B (en) |
DE (1) | DE102018124664A1 (en) |
WO (1) | WO2020069942A1 (en) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2721316C3 (en) * | 1977-05-04 | 1979-10-11 | Gebrueder Sulzer Ag, Winterthur (Schweiz) | Device for irradiating flowable material, in particular sewage sludge, by means of electron beams |
US4230947A (en) | 1979-07-02 | 1980-10-28 | High Voltage Engineering Corporation | Apparatus for treating flowable material |
US5009654A (en) * | 1989-03-10 | 1991-04-23 | Baxter International Inc. | Sterile product and method for sterilizing and assembling such product |
DE19942142B4 (en) | 1999-09-03 | 2004-04-15 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Process and device for treating bulk material, preferably seed, with accelerated electrons |
AU7397800A (en) * | 1999-09-24 | 2001-04-30 | Atomic Energy Of Canada Limited | Electron beam sterilization of contained liquids |
HUP0303580A2 (en) * | 2000-10-26 | 2004-01-28 | Atlantium Lasers Ltd | Disinfection through packaging |
ITTO20010372A1 (en) * | 2001-04-13 | 2002-10-13 | Silvio Perona | DEPURATION AND REFINING PROCESS OF FLUIDS BY MEANS OF ACCELERATED ELECTRONS. |
US20030174810A1 (en) * | 2002-03-12 | 2003-09-18 | Steris Inc. | Method and apparatus for destroying microbial contamination of mail |
DE10321654A1 (en) * | 2003-05-14 | 2004-12-09 | Leeser, Rolf, Dr.med. | Process for killing microorganisms |
EP1702678A1 (en) * | 2005-03-16 | 2006-09-20 | Glatt Systemtechnik GmbH | Apparatus for treatment of liquid with energetic radiation |
US8376013B2 (en) * | 2008-03-11 | 2013-02-19 | Duke University | Plasmonic assisted systems and methods for interior energy-activation from an exterior source |
DE102008028545A1 (en) * | 2008-06-16 | 2009-12-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method and device for inactivating a microbiologically contaminated mass containing solid particles by means of accelerated electrons |
EP2819708B1 (en) * | 2012-02-28 | 2017-08-02 | Life Technologies Corporation | Systems and containers for sterilizing a fluid |
DE102013012455A1 (en) * | 2013-07-26 | 2015-02-19 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method of inactivating viruses using electron beams |
DE102013111650B3 (en) * | 2013-10-23 | 2015-02-05 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Apparatus for generating accelerated electrons |
DE102016110672A1 (en) * | 2016-06-09 | 2017-12-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method for applying a fluid with accelerated electrons |
DE102016216573A1 (en) | 2016-09-01 | 2018-03-01 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Inactivation of pathogens in biological media |
-
2018
- 2018-10-05 DE DE102018124664.1A patent/DE102018124664A1/en active Pending
-
2019
- 2019-09-25 CN CN201980065229.4A patent/CN112789060B/en active Active
- 2019-09-25 KR KR1020217013577A patent/KR20210070353A/en active Search and Examination
- 2019-09-25 US US17/282,516 patent/US20210379218A1/en active Pending
- 2019-09-25 EP EP19778498.6A patent/EP3860662A1/en active Pending
- 2019-09-25 WO PCT/EP2019/075926 patent/WO2020069942A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20210379218A1 (en) | 2021-12-09 |
CN112789060B (en) | 2023-06-02 |
DE102018124664A1 (en) | 2020-04-09 |
KR20210070353A (en) | 2021-06-14 |
CN112789060A (en) | 2021-05-11 |
WO2020069942A1 (en) | 2020-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68924485T2 (en) | UV sterilization, esp. for blood products. | |
EP1968652B1 (en) | Method for irradiating thrombocyte concentrates in flexible containers with ultra-violet light | |
EP1962905B1 (en) | Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation | |
DE102008056551A1 (en) | Method for reducing the viral and microbial load of solids-containing biological extracts | |
WO2012150040A1 (en) | Method for deactivating preferably odour-relevant molecules and device for carrying out said method | |
DE102011100751A1 (en) | Method for inactivating odor-relevant molecules, particularly bacteria, of surface, involves generating plasma and inactivating odor-relevant molecules through influence of hot electrons of plasma on molecules to be inactivated | |
DE60101371T2 (en) | METHOD FOR PREVENTING THE PROPAGATION OF MICROORGANISMS IN AQUATIC SYSTEMS | |
EP2328623B1 (en) | Method for reducing the viral and microbial load of extracts containing solids and obtained from animal pancreas | |
WO2020069942A1 (en) | Method for inactivating biologically active components in a liquid | |
EP2135624B1 (en) | Method and device to inactivate a mass microbiologically contaminated and containing solid particles using accelerated electrons | |
DE102018115300A1 (en) | Arrangement and method for decontamination of objects | |
EP3861095A1 (en) | Method for stimulating the growth of biomass in a liquid inside a bioreactor | |
EP3732992A1 (en) | Assembly for decontaminating a surface of objects and method for decontaminating a surface of objects | |
DE102016216573A1 (en) | Inactivation of pathogens in biological media | |
WO2009036842A1 (en) | Method for reducing the number of viruses and microorganisms in biological extracts containing solids, and extracts produced according to this method | |
DE4221487C2 (en) | Process for disinfection using pressure and ultrasound | |
EP2855656B1 (en) | Cell culture container for one-time use | |
DE202020005219U1 (en) | Portable device for the production of bactericidal, virocidal and fungicidal aerosols by ionizing a spray solution, a gel or a powder substance with cold plasma to disinfect materials, objects and surfaces. | |
DE202015100806U1 (en) | Device for inactivating pathogens in fluids | |
EP3423114B1 (en) | Process and apparatus for small parts | |
DE102017107124A1 (en) | Powder for cleaning an internal body part and / or an implant, process for producing such a powder and suitable uses | |
DE314859C (en) | ||
DE1003398B (en) | Process for the manufacture of poliomyelitis virus vaccines | |
EP3725334A1 (en) | Device and method for reducing the number of germs | |
DE10321654A1 (en) | Process for killing microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210305 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. |